CD99r as marker for alpha and beta cells

CA3318852A1Pending Publication Date: 2025-08-21LANNER BIOLOGICS AB
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CA3318852
Authority / Receiving Office
CA · CA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-02-13
Filing Date
2025-02-11
Publication Date
2025-08-21
Patent Text Reader

Abstract

A method for enriching glucagon producing alpha cells and / or insulin producing beta cells in a mixture of cells, comprising labelling the cell surface marker CD99R in a starting mixture of cells with a label and separating the cells that are positive for the cell surface marker from cells that are negative for the cell surface marker to obtain a final mixture of cells that is more enriched in alpha cells and / or beta cells compared to the starting mixture. A use of an antibody specific for CD99R for detecting glucagon producing alpha cells and / or insulin producing beta cells.
Need to check novelty before this filing date? Find Prior Art